I absolutely hear the hon. Member’s argument, and similar points were made during the debate. As the Minister with oversight of major conditions, cystic fibrosis is not the only condition about which I have received letters, parliamentary questions and lobbying in general asking for exemptions to prescription charges. We cannot just look at cystic fibrosis in isolation; a similar argument could be made in relation to a number of other conditions. As I have set out, the way the system works is specifically designed to help people on low incomes with the cost of prescriptions and make it more affordable for people who have to get a lot of prescriptions during the course of a year.
Cystic Fibrosis: Living Costs
Proceeding contribution from
Helen Whately
(Conservative)
in the House of Commons on Thursday, 2 February 2023.
It occurred during Backbench debate on Cystic Fibrosis: Living Costs.
About this proceeding contribution
Reference
727 c186WH Session
2022-23Chamber / Committee
Westminster HallSubjects
Librarians' tools
Timestamp
2023-02-13 14:52:49 +0000
URI
http://hansard.intranet.data.parliament.uk/Commons/2023-02-02/23020240000122
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2023-02-02/23020240000122
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2023-02-02/23020240000122